[{"indications": "Indications\u00a0adjuvant treatment of oestrogen-receptor-positive early invasive\r\nbreast cancer in postmenopausal women; adjuvant treatment of oestrogen-receptor-positive\r\nearly breast cancer in postmenopausal women following 2\u20133 years of\r\ntamoxifen therapy; advanced breast cancer in postmenopausal women\r\nwhich is oestrogen-receptor-positive or responsive to tamoxifen", "name": "ANASTROZOLE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.3 Sex hormones and hormone antagonists in malignant disease", "8.3.4 Hormone antagonists", "8.3.4.1 Breast cancer"], "cautions": "Cautions\u00a0laboratory test for menopause if doubt; susceptibility to osteoporosis (assess bone mineral density before treatment and at regular intervals)", "side-effects": "Side-effects\u00a0hot flushes, vaginal dryness, vaginal bleeding,\r\nhair thinning, anorexia, nausea, vomiting, diarrhoea, headache, arthralgia,\r\narthritis, bone fractures, bone pain, rash (including Stevens-Johnson\r\nsyndrome), cutaneous vasculitis; asthenia and drowsiness\u2014may initially\r\naffect ability to drive or operate machinery; slight increases in\r\ntotal cholesterol levels reported; very rarely allergic reactions\r\nincluding angioedema and anaphylaxis", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/36794.htm", "doses": ["1\u00a0mg daily"], "pregnancy": "Pregnancy\u00a0avoid"}]